Ticker LaunchCanada to US · Cross-listing · CYBN
Cybin Inc.
Cybin Inc. (CYBN), a British Columbia-based company, cross-listed on NYSE American on Jul 26, 2021, registering its securities on Form 40FR12B.
Cybin Inc. is a biotechnology company advancing therapies, delivery mechanisms and novel compounds as potential treatments for psychiatric and neurological conditions. It is developing psychedelic-based molecules and delivery systems intended to improve pharmacokinetics.
- Type
- Cross-listing
- US exchange
- NYSE American
- Ticker
- CYBN
- Listed
- Jul 26, 2021
- Province
- British Columbia
- Registration form
- 40FR12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (40FR12B) Jul 26, 2021
- All filings on EDGAR CIK 1833141
Other Canadian companies listing in the US
- Bragg Gaming Group Inc.Nasdaq · Aug 25, 2021
- VIQ Solutions Inc.Nasdaq · Aug 6, 2021
- Cardiol Therapeutics Inc.Nasdaq · Aug 4, 2021
- Draganfly Inc.Nasdaq · Jul 28, 2021
- Field Trip Health Ltd. (now Reunion Neuroscience Inc.)Nasdaq · Jul 19, 2021
- Standard Lithium Ltd.NYSE American · Jun 30, 2021